Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Mannelli

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
JAMA|December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomasLi Yao, Francesca Schiavi, Alberto Cascon, et al.
Nature Reviews. Endocrinology|May 22, 2021
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriersLaurence Amar, Karel Pacak, Olivier Steichen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical CancerAnne Jouinot, Guillaume Assie, Rossella Libe, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Theranostics|August 15, 2019
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paragangliomaBruna Calsina, Luis Jaime Castro-Vega, Rafael Torres-Pérez, et al.
The Journal of Molecular Diagnostics : JMD|May 30, 2017
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma DiagnosticsMaria Currás-Freixes, Elena Piñeiro-Yañez, Cristina Montero-Conde, et al.
The Lancet. Oncology|July 7, 2009
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysisFrancien H van Nederveen, José Gaal, Judith Favier, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
JAMA|December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomasLi Yao, Francesca Schiavi, Alberto Cascon, et al.
Nature Reviews. Endocrinology|May 22, 2021
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriersLaurence Amar, Karel Pacak, Olivier Steichen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical CancerAnne Jouinot, Guillaume Assie, Rossella Libe, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Theranostics|August 15, 2019
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paragangliomaBruna Calsina, Luis Jaime Castro-Vega, Rafael Torres-Pérez, et al.
The Journal of Molecular Diagnostics : JMD|May 30, 2017
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma DiagnosticsMaria Currás-Freixes, Elena Piñeiro-Yañez, Cristina Montero-Conde, et al.
The Lancet. Oncology|July 7, 2009
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysisFrancien H van Nederveen, José Gaal, Judith Favier, et al.
Pageof 14